Literature DB >> 2220602

Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure.

A T Hirsch1, Y M Pinto, H Schunkert, V J Dzau.   

Abstract

The circulating renin-angiotensin system (RAS) plays an important role in the maintenance of cardiovascular homeostasis. It has recently been demonstrated that endogenous RAS exist in target tissues that are important in cardiovascular regulation. This article reviews the multiple effects of angiotensin II in target tissues, the evidence for the presence of functional tissue RAS and the data that suggest a role for these tissue RAS in the pathophysiology of heart failure. Activation of circulating neurohormones is predictive of worsened survival in heart failure; however, cardiac and renal tissue RAS activities are also increased in the compensated stage of heart failure, when plasma renin-angiotensin activity is normal. It is hypothesized that the plasma RAS maintains circulatory homeostasis during acute cardiac decompensation, while changes in tissue RAS contribute to homeostatic responses during chronic sustained cardiac impairment. This concept of different functions of circulating and tissue RAS in the pathophysiology of heart failure may have important pharmacologic implications.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2220602     DOI: 10.1016/0002-9149(90)90473-e

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  19 in total

Review 1.  Novel drugs and current therapeutic approaches in the treatment of heart failure.

Authors:  V V Bonarjee; K Dickstein
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

Review 2.  Activated tissue renin-angiotensin systems add to the progression of heart failure.

Authors:  Y M Pinto; H Buikema; W H van Gilst; K I Lie
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

3.  Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?

Authors:  Martin W Dünser; Jens Meier
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.

Authors:  Melissa A Cadnapaphornchai; Diana M George; Amirali Masoumi; Kim McFann; John D Strain; Robert W Schrier
Journal:  Contemp Clin Trials       Date:  2011-01-23       Impact factor: 2.226

Review 5.  Hypertension as a risk factor for heart failure.

Authors:  Arun Kannan; Rajesh Janardhanan
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

6.  Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.

Authors:  H Buikema; S H Monnink; R A Tio; H J Crijns; D de Zeeuw; W H van Gilst
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

7.  Mast cell renin and a local renin-angiotensin system in the airway: role in bronchoconstriction.

Authors:  Arul Veerappan; Alicia C Reid; Racha Estephan; Nathan O'Connor; Maria Thadani-Mulero; Mariselis Salazar-Rodriguez; Roberto Levi; Randi B Silver
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

8.  Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries.

Authors:  Kultigin Turkmen; Huseyin Oflaz; Bora Uslu; Arif O Cimen; Ali Elitok; Erdem Kasikcioglu; Sabahat Alisir; Fatih Tufan; Sule Namli; Mukremin Uysal; Tevfik Ecder
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 8.237

Review 9.  Cardiorenal syndrome and the role of ultrafiltration in heart failure.

Authors:  Jason Prosek; Anil Agarwal; Samir V Parikh
Journal:  Curr Heart Fail Rep       Date:  2013-03

10.  Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches.

Authors:  Katerina Koniari; John Parissis; Ioannis Paraskevaidis; Maria Anastasiou-Nana
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.